There has been controversy around aducanumab, which targets the cause rather than the symptoms.
from BBC News - World https://bbc.in/2SjRSiZ
Post Top Ad
Responsive Ads Here
Monday, June 7, 2021
US approves first new Alzheimer's drug in 20 years
Subscribe to:
Post Comments (Atom)
Post Bottom Ad
Responsive Ads Here
No comments:
Post a Comment